ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0188

Association Between Area Deprivation Index and Organ Damage Accumulation in a Statewide Incident Lupus Cohort

Jonathan Katz1, Bryn Sutherland2, Ang Yu3, Jenna Cormier2, Yiran Jiang2, David Gazeley4, Felix Elwert3 and Christie M. Bartels5, 1Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, 2Medical College of Wisconsin, Milwaukee, WI, 3Department of Sociology, University of Wisconsin, Madison, WI, 4Medical College of Wisconsin, Wauwatosa, WI, 5University of Wisconsin, School of Medicine and Public Health, Madison, WI

Meeting: ACR Convergence 2023

Keywords: Cohort Study, Demographics, Disease Activity, socioeconomic factors, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0176–0195) Healthcare Disparities in Rheumatology Poster I: Lupus

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic Lupus Erythematosus (SLE) is a heterogenous systemic autoinflammatory disease that disproportionately effects young women and minoritized populations. Disparities are multifactorial with genetic, hormonal, and environmental contributors. Literature has implicated the role of social determinants of health, specifically low individual socioeconomic status (SES) not just with SLE risk, but also cumulative SLE end organ damage due to disease and consequences of therapy. The area deprivation index (ADI) describes neighborhood social risk by integrating 17 census block factors that correlate with many disease outcomes. We hypothesized that patients with incident SLE in more disadvantaged ADI neighborhoods would more rapidly accumulate damage compared to more advantaged ADI groups.

Methods: This observational cohort study included incident SLE patients from three systems representing urban, suburban, and rural patients across one state.  Abstractors manually validated incident SLE cases that fulfilled the 1997 American College of Rheumatology (ACR) and 2012 SLE International Collaborating Clinics (SLICC) criteria. Sociodemographic data and diagnoses related to end organ damage through 2020 were manually abstracted. We used the original US ADI publication to produce ADI rank quintiles. Time to damage, as defined by abstracted events of the SLICC/ACR Damage Index, was assessed at SLE diagnosis and through death or study end (12/31/2020). We used Cox regression to estimate survival curves of time to first damage event from SLE diagnosis stratified by ADI to test our hypothesis.

Results: In a total cohort of 611 incident lupus cases, 524 had complete data. Table 1 shows 88% female and 88% White patients with a low proportion in the most disadvantaged US ADI group. Of those in the most disadvantaged ADI, 67% came from the urban system. Figure 1A shows survival curves of patients from the urban system demonstrating a trend of reduced damage-free survival within the most disadvantaged ADI (median 806 days) compared to those more advantaged (least disadvantaged median 1100 days; log rank insignificant). Total cohort survival (Figure 1B) showed no significant association by ADI. Table 2 shows multivariable hazards with no significance by ADI; significance for age, smoking, and baseline renal disease.

Conclusion: While many studies have investigated associations between individual SES and SLE, ours is among the first to investigate the relationship between neighborhood SES, measured by ADI, and damage in incident SLE. In contrast to our hypothesis, ADI was not statistically associated with damage-free survival. The urban cohort demonstrated the expected reduced damage-free survival trend in the most disadvantaged ADI, suggesting high neighborhood disadvantage may impact SLE damage.  Limitations include risk of sampling bias with the small sample size of the most disadvantaged ADI group. Furthermore, neighborhood-level factors may be distinct between urban vs non-urban areas; more research is needed to determine if or how neighborhood disadvantage impacts outcomes in SLE.

Supporting image 1

Table 1. Statewide Incident Lupus Cohort Demographics

Supporting image 2

Figure 1. Damage-Free Survival Curves by Area Deprivation Index (ADI).
First ADI is most disadvantaged. A. Urban Cohort B. Statewide Cohort

Supporting image 3

Table 2. Adjusted Hazard Ratios for Time to First SLE Damage Event


Disclosures: J. Katz: None; B. Sutherland: None; A. Yu: None; J. Cormier: None; Y. Jiang: None; D. Gazeley: None; F. Elwert: None; C. Bartels: Pfizer, 5.

To cite this abstract in AMA style:

Katz J, Sutherland B, Yu A, Cormier J, Jiang Y, Gazeley D, Elwert F, Bartels C. Association Between Area Deprivation Index and Organ Damage Accumulation in a Statewide Incident Lupus Cohort [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/association-between-area-deprivation-index-and-organ-damage-accumulation-in-a-statewide-incident-lupus-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-between-area-deprivation-index-and-organ-damage-accumulation-in-a-statewide-incident-lupus-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology